Literature DB >> 23552262

Status of neurocognitive and oxidative stress conditions in iron-steel workers.

Ali Akbar Malekirad1, Mansuoreh Mirabdollahi2, Ali Asghar Pilehvarian2, Ali Reza Nassajpour2, Mohammad Abdollahi3.   

Abstract

The aim of this study was to determine oxidative stress status as well as ferrous (Fe) and Copper (Cu) levels in blood, neurocognitive impairment, and clinical markers in iron-steel workers. A comparative cross-sectional analysis was performed in 50 iron-steel workers who have been in contact with Fe and Cu in comparison with a control group containing 50 healthy subjects in the same age group and sex. Blood levels of lipid peroxidation, total antioxidant capacity, Fe, and Cu along with neurocognitive impairment were measured in workers and controls. Clinical examination was accomplished to record any abnormal sign or symptoms. Comparing with controls, the workers showed higher blood levels of lipid peroxidation and Cu and also a lower total antioxidant capacity. There was a positive correlation between work history and interstitial lung disease that strengths the presumption to progress to chronic obstructive lung disease in future. The results indicate that exposure to a combination of Fe and Cu in iron-steel workers induces oxidative stress. Especially, in the present case, toxic effect of Cu has been more than positive effects of Fe, but the combined exposure resulted in no such critical toxicity.
© The Author(s) 2013.

Entities:  

Keywords:  Ferrous; copper; iron–steel workers; oxidative stress; toxicity

Mesh:

Substances:

Year:  2013        PMID: 23552262     DOI: 10.1177/0748233713483196

Source DB:  PubMed          Journal:  Toxicol Ind Health        ISSN: 0748-2337            Impact factor:   2.273


  1 in total

1.  Oxidative stress and early DNA damage in workers exposed to iron-rich metal fumes.

Authors:  Masoud Pandeh; Saedeh Fathi; Mohammad Javad Zare Sakhvidi; Javad Zavar Reza; Lyla Sedghian
Journal:  Environ Sci Pollut Res Int       Date:  2017-03-01       Impact factor: 4.223

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.